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This editorial refers to ‘Enhanced prognostic value from
cardiopulmonary exercise testing in chronic heart
failure by non-linear analysis: oxygen uptake efﬁciency
slope’‡ by L. Ceri Davies et al., on page 684
It is reported in several papers, and is widely accepted by
most scientists, that cardiopulmonary exercise test (CPET)
is the best way to evaluate exercise capacity and, more
importantly, to identify the prognosis of chronic heart
failure patients.1 However, several technical issues can
effectively inﬂuence the results obtained by CPET. Some of
these issues are known, but frequently forgotten or
ignored, and some are simply unknown. I will report a few
examples. First, we have known since the work of Elborn
et al.2 that for properly determined peak oxygen consump-
tion (VO2) in heart failure patients, a familiarization pro-
cedure is needed. Unfortunately, it is unclear how often
this is done in either clinical practice or research studies.
It seems to me that familiarization procedures are almost
never done or, in any case, are almost never reported with
the underlying concept that nobody is paying for the
second test. Secondly, we have known for many years that
ergometers are different. Indeed, we know that, in normal
subjects, peak VO2 is 10% greater with treadmill than
with cyclo-ergometer,3 but it is unknown whether this is
true in heart failure as well. Furthermore, it is also
unknown whether walking and biking generate comparable
cardiovascular responses in heart failure subjects, although
we do know that it is not the case in respiratory patients.4
Thirdly, which protocol should be chosen? It is now clear
that an exercise should last around 10 min and that a
protocol which generates a shorter or longer exercise by
itself affects measurements.5 However, a personalized
ramp protocol is rarely used. Indeed, in the great majority
of studies, a standard incremental protocol, such as
10 W/min for the cyclo-ergometer or a modiﬁed Bruce pro-
tocol for the treadmill, is used in heart failure, but exercise
capacity is different among heart failure patients. For
example, a 10 W/min test which lasts, as it should,
10 min, implies that workload at peak exercise is 100 W, a
workload which is rarely obtained in heart failure.
Furthermore, the exercise duration is only occasionally
reported, so that, I believe, we are frequently dealing
with data obtained by test which is often too short and
sometimes, though more rarely, too long.
Another issue which is unclear is which CPET parameter
we should look at ﬁrst. Parameters can be grouped into
two major categories: the VO2-related parameters and the
ventilation (VE)-related parameters. These two groups
analyse two different but interrelated aspects of exercise
performance in heart failure. The VO2-related parameters
depend on the efﬁcacy of VE, which includes lung diffusion,
cardiac output, oxygen extraction by the muscles, and
muscle function, whereas the VE-related parameters
depend on the ventilatory efﬁciency which is related to
reﬂex activity, dead space VE, and, possibly, the amount
of gas to be exchanged. So, none of these parameters
looks at a singular body function. Another issue is that
several parameters are related to a speciﬁc moment of
exercise, such as peak or the anaerobic threshold, and it
is crucial to precisely deﬁne these speciﬁc moments: is
peak the real peak, is anaerobic threshold determination
correct, and so on. In the recent years, more attention
has been dedicated to gas kinetics analysis. This has the
advantage of not being related to a speciﬁc time frame,
although it might suffer from its difﬁcult mathematical
approach and from the pretence that a single phenomenon
guides a process throughout the entire exercise. The fact
that none of the possible parameters obtained by CPET is
‘the perfect prognostic parameter for heart failure’,
regardless of heart failure severity or treatment, can be
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conﬁrmed by the plethora of tentatives to improve prognos-
tic capability done by adding to CPET parameters one or
more non-CPET variables such as cardiac output,6 blood
pressure,7 or several parameters grouped in more complex
scores.8
Ceri Davies et al.9 bring our attention to the oxygen
uptake efﬁciency slope (OUES), an index obtained by ana-
lysing VO2 and VE kinetics. Indeed, OUES is obtained by the
mathematical analysis of the VE/VO2 relationship. It is an
attempt to combine VO2 with VE-related parameters.
OUES is a good prognostic indicator which remains so also
if only a portion, as low as 50%, of the exercise is evalu-
ated. This is an extremely important ﬁnding. Apparently,
in this regard, OUES is better than VE/VCO2, but in Ceri
Davies study,9 as in many other studies,10 the VE/VCO2
relationship is calculated throughout the entire exercise,
even though it is well known that, due to acidosis-
induced hyperventilation, the slope of the VE/VCO2
relationship is steeper in the last part of the exercise.
However, before extensive application of OUES can be
carried out in clinical practice, a few issues should be
resolved: (i) Is OUES related to exercise duration? (ii) Is
OUES obtained with a treadmill exercise similar to that
obtained with a cyclo-ergometer exercise? (iii) Is OUES
the same at altitude? So, as is usually the case in an
intriguing paper, more questions are brought out than
answers.
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